Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Calico
Biotech
Alphabet's Calico weaves anti-aging deal with China's Mabwell
Alphabet’s Calico is inking a deal worth up to $571 million biobucks for rights to Mabwell's IL-11-targeting mAb for age-related diseases.
Gabrielle Masson
Jun 26, 2025 4:52pm
Rival AbbVie and Denali prospects flunk phase 2/3 ALS tests
Jan 7, 2025 5:52am
Terray assembles $120M series B to advance AI-powered molecules
Oct 17, 2024 10:37am
John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders
Mar 29, 2024 9:30am
AbbVie and Calico drug boosts immunotherapy response in mice
Oct 5, 2023 11:19am
AbbVie hits go on $1B re-upped Calico deal
Jul 27, 2021 10:13am